ASBP
Aspire BioPharma, Inc.
NASDAQ: ASBP · HEALTHCARE · BIOTECHNOLOGY
$0.22
-9.30% today
Updated 2026-04-30
Market cap
$1.03M
P/E ratio
—
P/S ratio
166.07x
EPS (TTM)
$-16.38
Dividend yield
—
52W range
$0 – $35
Volume
12.1M
Aspire BioPharma, Inc. (ASBP) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-43,404.00%
ROE
0.00%
ROA
-446.90%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2021 | — | $-25475.00 | — | — | — |
| 2022 | $0.00 | $3.34M | — | — | — |
| 2023 | $0.00 | $4.46M | — | — | — |
| 2024 | $0.00 | $-12.54M | — | — | — |
| 2025 | $6202.00 | $-24.48M | -1.87% | -312,016.95% | -394,725.06% |